A clinical trial undertaken around the world for treating excessive daytime sleepiness in subjects with obstructive sleep apnea. These patients are randomly given a drug or an inactive drug to increa...

Mise à jour : Il y a 4 ans
Référence : EUCTR2014-005514-31

A clinical trial undertaken around the world for treating excessive daytime sleepiness in subjects with obstructive sleep apnea. These patients are randomly given a drug or an inactive drug to increase their ability to stay awake throughout the day

Femme et Homme

  • | Pays :
  • -
  • | Organes :
  • -
  • | Spécialités :
  • -

Extrait

To evaluate the efficacy of JZP-110 administered once daily for up to 12 weeks in doses of 37.5, 75, 150, and 300 mg compared to placebo in the treatment of excessive sleepiness in adult subjects with OSA.


Critère d'inclusion

  • Treatment of excessive sleepiness in adult patients with obstructive sleep apnea; to increase the ability to stay awake throughout the day